PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas Ca

NCT00467116 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

BIOLOGICAL: cetuximab
DRUG: gemcitabine hydrochloride
RADIATION: radiation therapy

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]